Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system - PubMed (original) (raw)
Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system
Michael Y Chen et al. J Neurosurg. 2005 Aug.
Abstract
Object: Achieving distribution of gene-carrying vectors is a major barrier to the clinical application of gene therapy. Because of the blood-brain barrier, the distribution of genetic vectors to the central nervous system (CNS) is even more challenging than delivery to other tissues. Direct intraparenchymal microinfusion, a minimally invasive technique, uses bulk flow (convection) to distribute suspensions of macromolecules widely through the extracellular space (convection-enhanced delivery [CED]). Although acute injection into solid tissue is often used for delivery of oligonucleotides, viruses, and liposomes, and there is preliminary evidence that certain of these large particles can spread through the interstitial space of the brain by the use of convection, the use of CED for distribution of viruses in the brain has not been systematically examined. That is the goal of this study.
Methods: Investigators used a rodent model to examine the influence of size, osmolarity of buffering solutions, and surface coating on the volumetric distribution of virus-sized nanoparticles and viruses (adeno-associated viruses and adenoviruses) in the gray matter of the brain. The results demonstrate that channels in the extracellular space of gray matter in the brain are large enough to accommodate virus-sized particles and that the surface characteristics are critical determinants for distribution of viruses in the brain by convection.
Conclusions: These results indicate that convective distribution can be used to distribute therapeutic viral vectors in the CNS.
Similar articles
- Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles.
Szerlip NJ, Walbridge S, Yang L, Morrison PF, Degen JW, Jarrell ST, Kouri J, Kerr PB, Kotin R, Oldfield EH, Lonser RR. Szerlip NJ, et al. J Neurosurg. 2007 Sep;107(3):560-7. doi: 10.3171/JNS-07/09/0560. J Neurosurg. 2007. PMID: 17886556 - Convection-enhanced delivery in intact and lesioned peripheral nerve.
Ratliff JK, Oldfield EH. Ratliff JK, et al. J Neurosurg. 2001 Dec;95(6):1001-11. doi: 10.3171/jns.2001.95.6.1001. J Neurosurg. 2001. PMID: 11765815 - Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.
Saito R, Krauze MT, Noble CO, Tamas M, Drummond DC, Kirpotin DB, Berger MS, Park JW, Bankiewicz KS. Saito R, et al. J Neurosci Methods. 2006 Jun 30;154(1-2):225-32. doi: 10.1016/j.jneumeth.2005.12.027. Epub 2006 Feb 10. J Neurosci Methods. 2006. PMID: 16472868 - Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders.
Lonser RR, Akhter AS, Zabek M, Elder JB, Bankiewicz KS. Lonser RR, et al. J Neurosurg. 2020 Jul 10;134(6):1751-1763. doi: 10.3171/2020.4.JNS20701. Print 2021 Jun 1. J Neurosurg. 2020. PMID: 32915526 Review. - Convection-enhanced delivery to the central nervous system.
Lonser RR, Sarntinoranont M, Morrison PF, Oldfield EH. Lonser RR, et al. J Neurosurg. 2015 Mar;122(3):697-706. doi: 10.3171/2014.10.JNS14229. Epub 2014 Nov 14. J Neurosurg. 2015. PMID: 25397365 Review.
Cited by
- Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery.
Hadjipanayis CG, Fellows-Mayle W, Deluca NA. Hadjipanayis CG, et al. Mol Ther. 2008 Nov;16(11):1783-8. doi: 10.1038/mt.2008.185. Epub 2008 Aug 26. Mol Ther. 2008. PMID: 18728637 Free PMC article. - Polymeric nanoparticles for drug delivery to the central nervous system.
Patel T, Zhou J, Piepmeier JM, Saltzman WM. Patel T, et al. Adv Drug Deliv Rev. 2012 May 15;64(7):701-5. doi: 10.1016/j.addr.2011.12.006. Epub 2011 Dec 20. Adv Drug Deliv Rev. 2012. PMID: 22210134 Free PMC article. Review. - Clinical developments in nanotechnology for cancer therapy.
Heidel JD, Davis ME. Heidel JD, et al. Pharm Res. 2011 Feb;28(2):187-99. doi: 10.1007/s11095-010-0178-7. Epub 2010 Jun 12. Pharm Res. 2011. PMID: 20549313 Review. - Brief review: Applications of nanocomposite in electrochemical sensor and drugs delivery.
Haq Khan ZU, Khan TM, Khan A, Shah NS, Muhammad N, Tahir K, Iqbal J, Rahim A, Khasim S, Ahmad I, Shabbir K, Gul NS, Wu J. Haq Khan ZU, et al. Front Chem. 2023 Mar 16;11:1152217. doi: 10.3389/fchem.2023.1152217. eCollection 2023. Front Chem. 2023. PMID: 37007050 Free PMC article. Review. - Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy.
Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG. Wankhede M, et al. Expert Rev Clin Pharmacol. 2012 Mar;5(2):173-86. doi: 10.1586/ecp.12.1. Expert Rev Clin Pharmacol. 2012. PMID: 22390560 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical